Where does Lungpacer Medical Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Lungpacer Medical Inc. ranks #8,245 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Lungpacer Medical Inc. hold?

Lungpacer Medical Inc. holds 39 US utility patents granted between 2017 and 2025, spanning 10 technology areas.

What is Lungpacer Medical Inc.'s Innovation Score?

Lungpacer Medical Inc. has an Innovation Score of 42.6 out of 100 (top 30% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Lungpacer Medical Inc. focus on?

Lungpacer Medical Inc.'s top technology area is A61N (ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy) with 39 patents, ranking #97 of 1,943 assignees active in that subclass. Grants appear in 10 CPC subclasses total.

Is Lungpacer Medical Inc.'s patent grant rate increasing or decreasing?

Lungpacer Medical Inc.'s recent grant velocity is +100% compared to the prior five-year period (grant years, not application filing dates). This indicates accelerating grant output.

What does claim depth mean for Lungpacer Medical Inc.'s patents?

Lungpacer Medical Inc.'s patents average 20.8 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Lungpacer Medical Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Lungpacer Medical Inc.

USPTO PatentsView assignee record - 39 granted patents across 10 technology areas, recorded in grant years 2017–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61N (ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Lungpacer ranks #8,245 of 49,997 tracked US assignees by granted-patent volume, with 39 patents across 10 technology areas.

#8,245
of 49,997 US assignees by volume: Top 30%
by Innovation Score (42.6/100): 20.8
avg claims per patent: +100%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R8245 · Foreign Corporation #8,245 · 39 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-DENSE · TYPE-FRNCORP · VEL-SURGE · BOOK-FULL

GRANTS-SMALL 39 grants
UPPER-Q #8,245/49,997
PHOTO-FINISH Latency
CPC-FOCUS A61N · 10 areas
INNOV-PAR 42.6/100
CLAIMS-DENSE 20.8 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-SURGE +100% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Latency, LLC (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Lungpacer’s 42.6 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 12.7 pts (30%) Velocity 6.2 pts (15%) Breadth 11.2 pts (26%) Claim depth 12.5 pts (29%)

Qualcomm Incorporated · highest

85
Ashley Diana Black… · near

43
Kunshan New Flat… · near

43
Lungpacer Medical · this assignee

43
All Purpose Networks · near

43
Won-Door · near

43
3D Lighting… · lowest

7

What this shows Lungpacer's Innovation Score is 42.6/100 (top 30% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Lungpacer?

Each dot is one of Lungpacer’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Lungpacer’s own 20.8 claims/patent is ABOVE the 12.5 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Lungpacer vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Lungpacer's grants concentrate

Lungpacer Medical Inc. is a focused PatentsView assignee: 10 CPC subclasses with 100% of grants classified under A61N (ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy). Peak complete grant year is 2024 (7 grants) versus a trough of 1 in 2017. By volume, Lungpacer sits between Longitude Flash Memory Solutions Ltd. and Miltenyi Biotec, Inc..

Lungpacer's three-year grant acceleration

Lungpacer Medical Inc. shows 14 grants in 2022–2024 against only 15 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Longitude Flash M…

39
LS Automotive

39
Latency

39
Lechat

39
Luxvue Technology

39
Meijo University

39
Mercari

39
Miltenyi Biotec

39
Lungpacer Medical ◀

39

What this shows Lungpacer holds 39 patents at rank #8,244, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Lungpacer

By rank, the assignees closest to #8,244 in granted patent volume.

Leaders in A61N (Electrotherapy)

Other assignees with the most granted patents in Lungpacer's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Lungpacer, neither rank-band nor same-CPC leaders (those blocks stay above). In A61N (Electrotherapy), Lungpacer ranks #97 of 1,943 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (43 here).

Kunshan New Flat Panel Display Technology Center Co., Ltd. 43 Ashley Diana Black International Holdings, LLC 43 All Purpose Networks, Inc. 43 Won-Door Corporation 43

Lungpacer's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

43 Top 30% higher than 70% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2017–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2017–2019 baseline. Full figures in the table below.

View data table

Lungpacer Medical Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2017	1	2.6%
2018	6	15.4%
2019	5	12.8%
2020	5	12.8%
2021	5	12.8%
2022	4	10.3%
2023	3	7.7%
2024	7	17.9%
2025partial year	3	7.7%

Which technologies does Lungpacer Medical Inc. patent most?

A61N - ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy 39

A61B - DIAGNOSIS; SURGERY; Identification 21

A61M - Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor 16

G16H - Healthcare Informatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR THE Handling OR Processing OF Medical OR Healthcare Data 6

H04J - Multiplex Communication 5

H03M - CODING; DECODING; Code Conversion IN General 5

H04L - Transmission OF Digital Information, e.g. Telegraphic Communication 5

G06F - Electric Digital Data Processing 3

A61H - Physical Therapy Apparatus, e.g. Devices FOR Locating OR Stimulating Reflex Points IN THE BODY; Artificial RESPIRATION; MASSAGE; Bathing Devices FOR Special Therapeutic OR Hygienic Purposes OR Specific Parts OF THE Body 2

H05K - Printed CIRCUITS; Casings OR Constructional Details OF Electric APPARATUS; Manufacture OF Assemblages OF Electrical Components 2

Top 10 of 10 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Lungpacer Medical Inc.'s patent record in context - here's where to go next.

Lungpacer Medical Inc.'s lead technology class is A61N (ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy), 100% of its portfolio - see every assignee active in that class. Explore A61N
Ranked #8,245 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Lungpacer Medical Inc. against Longitude Flash Memory Solutions Ltd., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 42.6/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.